Developing anti-aging skincare and therapies, spun out of Weill Cornell Medicine.


An early-stage investment by the Partnership Fund to support the commercialization of university-based research and the growth of life sciences in New York City.


Repairogen’s novel technology improves the skin’s natural DNA-repair process, which improves skin elasticity, reduces lines and wrinkles, and improves skin tone.

Visit site